FITLIFE BRANDS, INC. (FTLF) Earnings History

FITLIFE BRANDS, INC. - Q3 2025 Earnings

Filed at: Nov 13, 2025, 7:45 AM EST|Read from source

EXECUTIVE SUMMARY

FitLife Brands reported a significant revenue increase driven by the Irwin Naturals acquisition, but experienced a decline in net income and margins due to acquisition-related expenses and increased costs. While wholesale revenue surged, online revenue saw a slight decrease.

POSITIVE HIGHLIGHTS

  • •

    Total revenue increased 47% to $23.5 million, largely due to the Irwin acquisition contributing $6.8 million.

    positive
  • •

    Wholesale revenue surged 156% to $13.2 million, representing 56% of total revenue.

    positive
  • •

    Adjusted EBITDA increased 6% to $3.8 million compared to the prior year.

    positive
  • •

    MusclePharm organic revenue increased 55% year-over-year.

    positive

CONCERNS & RISKS

  • •

    Net income decreased to $0.9 million from $2.1 million in the prior year, primarily due to acquisition transaction expenses, lower gross margin, and higher income tax expense.

    negative
  • •

    Gross margin declined to 37.2% from 43.8% in the prior year, impacted by the Irwin acquisition's inventory step-up and increased whey protein costs for MusclePharm.

    attention
  • •

    Online revenue decreased 5% to $10.3 million, with declines in MRC and MusclePharm brands.

    attention
  • •

    Management cited increasing whey protein costs and general consumer weakness as primary concerns.

    negative

FINANCIAL METRICS

Revenue
Quarterly
$23.48M
+47.0%
Prior year: $15.98M
Net Income
Quarterly
$921.00K
-56.7%
Prior year: $2.13M
Annual (YTD)
$4.69M
N/A
Prior year: $6.91M
EPS (Diluted)
Quarterly
$0.09
-57.1%
Prior year: $0.21
Annual (YTD)
$0.47
N/A
Prior year: $0.70
Operating Income
Quarterly
$2.32M
-27.2%
Prior year: $3.18M
Annual (YTD)
$7.79M
N/A
Prior year: $10.24M
EPS (Basic)
Quarterly
$0.10
-56.5%
Prior year: $0.23
Annual (YTD)
$0.50
N/A
Prior year: $0.75

MARGIN ANALYSIS

Gross Margin
Current Quarter
37.2%
Prior Year
43.8%
YoY Change
-660 bps
Operating Margin
Current Quarter
9.9%
Prior Year
19.9%
YoY Change
-1004 bps
Net Margin
Current Quarter
3.9%
Prior Year
13.3%
YoY Change
-939 bps

Margin expansion indicates improving profitability and operational efficiency. Measured in basis points (bps): 100 bps = 1.0%.

SPECIAL ITEMS & ADJUSTMENTS

Q3 2025
Amortization of inventory step-up related to Irwin acquisition
Reduced gross margin to 37.2% from 38.9% on an adjusted basis.
+$0.4M
Q3 2025
Merger and acquisition related expenses
Contributed to the decline in net income.
+$0.82M
Total Impact
+$1.22M

Special items are non-recurring events that may distort period-over-period comparisons. Analysts typically adjust for these when calculating normalized earnings.

MANAGEMENT COMMENTARY

Encouraged by performance of MusclePharm (55% organic revenue growth) and Legacy FitLife excluding MRC (8% organic revenue growth).

— FITLIFE BRANDS, INC., Q3 2025 2025 Earnings Call

MusclePharm margins were lower due to absorbing increasing protein costs to gain market share.

— FITLIFE BRANDS, INC., Q3 2025 2025 Earnings Call

Irwin acquisition is off to a good start, with revenue impacted by pre-acquisition shipments and a strategic shift away from a key wholesale partner on Amazon.

— FITLIFE BRANDS, INC., Q3 2025 2025 Earnings Call

Commentary excerpts from earnings call transcripts provide management's perspective on performance, strategy, and outlook. Always review full transcripts for complete context.

OPERATIONAL METRICS

Irwin Gross Margin Pct Excluding Step Up
37.9
Prior year: 32.3
percent
Irwin Wholesale Revenue Impacted By Pull Forward
-0.6
million USD
Legacy Fitlife Organic Revenue Excluding Mrc
8
percent
Musclepharm Gross Margin Pct
19.8
Prior year: 35.5
percent
Musclepharm Revenue Growth
55
percent
Musclepharm Wholesale Revenue Growth
112
percent
Online Revenue Growth Excluding Irwin
-8
percent
Wholesale Revenue Growth Excluding Irwin
30
percent

Operational metrics provide insight into business drivers and customer engagement beyond traditional financial measures.